SmartTRAK will be hosting an Executive Briefing and Reception titled "Advanced Wound Care: Trends, Opportunities & Innovation"  at the 2018 SAWC Spring - The Symposium on Advanced Wound Care - on Wednesday, April 25th at 5pm in the Westin Charlotte Hotel, Uptown Room.

Moderated by Don Urbanowicz, Principal, Urbanowicz Consulting, the panel will include Susan Paquette, VP & GM Wound, BioMedGPS and Lennart Stadler, SmartTRAK's Senior Analyst, Wound Care. The discussion will focus on the latest trends and technologies impacting the Global Advanced Wound Care Market.
            

EWMA 2017, held in Amsterdam,  provided a unique and interesting look at the European Advanced Wound Care market - showcasing products approved for the European market but not yet launched in the US. Europe has always been a breeding ground for innovative medical devices, and has long served as a gateway for companies looking to bring new devices to the US. While some of these companies have no desire to enter the US market, many look to the US market with high expectations. It is the largest medical device market in the world, with one language and one regulatory and reimbursement system, and is much less complicated than the European market where distribution partnerships and regulatory approvals are sometimes needed for each country.

Q317 Infection Prevention: Vascular Access Adjunct Products 

A slowdown in growth for another quarter.

By Susan Paquette, VP Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market reached new market revenue heights in dollars and growth.

Q317 Market Recap Advanced Wound Care 

Biologics and single-use NPWT devices’ strong growth helps boost sluggish advanced dressing performance.

By Susan Paquette, VP Wound and
Lennart Stadler, Senior Analyst Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew in spite of a weak performance with market leaders.

SmartTRAK is excited to attend Desert Foot 2017 on Nov-29 through Dec-2, 2017  at the Grand Sheraton, Phoenix AZ. Desert Foot is the Annual Multi-Disciplinary Diabetic Limb Salvage Conference which honors our Federal Services Healthcare Professionals.

SmartTRAK is excited to be attending the ACS Clinical Congress 2017 on Oct 22-26, 2017 at the San Diego Convention Center in San Diego, California.

The hallmarks of the Clinical Congress are a broad range of outstanding hands-on and didactic learning opportunities and timely discourse on the most relevant surgical practices and research, along with unparalleled access to peers.

Please look for SmartTRAK's Susan Paquette, MS, MBA, Vice President and General Manager, Wound; Doug Devens, Senior Analyst, Biosurgery; Geoffrey Brown, Director Corporate Accounts, Wound Care. Contact Us for a meeting!

SmartTRAK had a great show at #SAWC2017! A few snaps from the show below and lots of great connections made by Lennart Stadler, Senior Analyst, Wound Care and Geoff Brown, Director Corporate Accounts, Wound Care. If you didn't get a chance to meet with them at the show, please don't hesitate to reach out!

And SmartTRAK's launch of new module Advanced China Dressings #woundcare was really well received. For a preview sample of the China Dressings module, click below.

SmartTRAK is excited to attend SAWC Fall on Oct 20-22, 2017 in Las Vegas at the beautiful Caesers Palace.  Please look for SmartTRAK's Lennart Stadler, Senior Analyst, Wound Care, who has flown all the way in from Sweden to attend the meeting. And it's also a great opportunity to meet with Geoffrey Brown,  Director Corporate Accounts, Wound Care, from Southern California!

BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence for the Surgical Wound Market with the addition of its newest module, US Hemostats & Sealants.

Reducing the recurrence of diabetic foot ulcers (DFU) or increasing ulcer free days is critical for patients with diabetes, as recurrence rates are 40% at one year, 66% at three years, and 75% at five years. At the DF Con meeting in Houston in March, BioMedGPS interviewed David G. Armstrong, DMP, MD, PhD, regarding his research on the use of fat grafting as a means to reduce recurrence of DFUs. Today, fat grafting is being rapidly adopted in plastic and reconstructive surgery, but is now being explored for care of the diabetic foot.